CIK 0000879407 · Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460408024
- Phone
- 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- 10-K Report Annual Report
- 4 Planned sale Chief Medical Officer sold 19,700 shares at an average $28.80 ($567,315)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Executive Officer sold 24,338 shares at $24.21 ($589,223)
- 4 Open-market sale Director sold 1,550 shares at $26.33 ($40,812)
- 144 Insider Sale of Securities
- 4 Open-market sale Chief Executive Officer sold 57,755 shares at an average $28.12 ($1,624,223)
- 144 Insider Sale of Securities
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Open-market sale Chief Commercial Officer sold 8,925 shares at $35.31 ($315,142)
- 4 Open-market sale Chief Discovery/Trans Medicine sold 3,000 shares at $35.53 ($106,590)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Chief Financial Officer sold 15,000 shares at $36.20 ($543,000)
- 144 Insider Sale of Securities
- SC 13G/A Stake Amended Statement of Ownership
- UPLOAD Other SEC-generated Letter
- 4 Open-market sale Director sold 6,500 shares at $40.90 ($265,850)
- 4 Open-market sale Chief Executive Officer sold 104,928 shares at an average $39.32 ($4,125,674)
Page 14 of 69 · 1,363 filings